This company listing is no longer active
Acasti Pharma Management
Management Kriterienprüfungen 0/4
Wichtige Informationen
Jan D'Alvise
Geschäftsführender
US$1.8m
Gesamtvergütung
| Prozentsatz des Geschäftsführergehalts | 25.1% |
| Amtszeit als Geschäftsführer | 6.8yrs |
| Eigentum des Geschäftsführers | 0.01% |
| Durchschnittliche Amtszeit des Managements | 1.6yrs |
| Durchschnittliche Amtszeit der Vorstandsmitglieder | 1.4yrs |
Analyse der Geschäftsführervergütung
| Datum | Gesamtvergütung | Gehalt | Unternehmensgewinne |
|---|---|---|---|
| Dec 31 2022 | n/a | n/a | -US$17m |
| Sep 30 2022 | n/a | n/a | -US$17m |
| Jun 30 2022 | n/a | n/a | -US$11m |
| Mar 31 2022 | US$2m | US$445k | -US$10m |
| Dec 31 2021 | n/a | n/a | -US$12m |
| Sep 30 2021 | n/a | n/a | -US$11m |
| Jun 30 2021 | n/a | n/a | -US$18m |
| Mar 31 2021 | US$582k | US$428k | -US$20m |
| Dec 31 2020 | n/a | n/a | US$3m |
| Sep 30 2020 | n/a | n/a | -US$6m |
| Jun 30 2020 | n/a | n/a | -US$21m |
| Mar 31 2020 | US$2m | US$411k | -US$26m |
| Dec 31 2019 | n/a | n/a | -US$56m |
| Sep 30 2019 | n/a | n/a | -US$46m |
| Jun 30 2019 | n/a | n/a | -US$42m |
| Mar 31 2019 | US$926k | US$373k | -US$39m |
| Dec 31 2018 | n/a | n/a | -US$31m |
| Sep 30 2018 | n/a | n/a | -US$34m |
| Jun 30 2018 | n/a | n/a | -US$20m |
| Mar 31 2018 | US$891k | US$337k | -US$17m |
| Mar 31 2017 | US$631k | US$275k | -US$8m |
Vergütung im Vergleich zum Markt: Jan's total compensation ($USD1.77M) is above average for companies of similar size in the Canadian market ($USD172.33K).
Entschädigung vs. Einkommen: Jan's compensation has increased whilst the company is unprofitable.
Geschäftsführer
Jan D'Alvise (67 yo)
6.8yrs
Amtszeit
US$1,773,841
Vergütung
Ms. Janelle D’Alvise, also known as Jan, has been an Independent Director of Spectral Medical Inc. since June 03, 2021. She is the Chairman of the board of The ObG Project. She has been the Chief Executive...
Führungsteam
| Name | Position | Amtszeit | Vergütung | Eigentümerschaft |
|---|---|---|---|---|
| President | 6.8yrs | US$1.77m | 0.015% $ 2.8k | |
| Co-Founder | 12.9yrs | US$905.45k | 0.0020% $ 377.0 | |
| Chief Financial Officer | 2.5yrs | US$847.55k | 0% $ 0 | |
| Chief Operating Officer of US | 1.6yrs | US$666.86k | 0% $ 0 | |
| Chief Commercial Officer | 1.2yrs | US$403.62k | 0.29% $ 55.2k | |
| Vice President of Quality & Compliance | 1.5yrs | keine Daten | keine Daten | |
| Senior Director of Human Resources | 1.2yrs | keine Daten | keine Daten |
1.6yrs
Durchschnittliche Betriebszugehörigkeit
61yo
Durchschnittliches Alter
Erfahrenes Management: ACST's management team is not considered experienced ( 1.6 years average tenure), which suggests a new team.
Vorstandsmitglieder
| Name | Position | Amtszeit | Vergütung | Eigentümerschaft |
|---|---|---|---|---|
| President | 6.7yrs | US$1.77m | 0.015% $ 2.8k | |
| Independent Director | 4.9yrs | US$131.60k | 0.011% $ 2.0k | |
| Independent Director | less than a year | US$6.00k | keine Daten | |
| Independent Director | 6.7yrs | US$134.10k | 0.028% $ 5.4k | |
| Member of Scientific Advisory Board | less than a year | keine Daten | keine Daten | |
| Independent Director | 1.6yrs | US$96.60k | 0% $ 0 | |
| Member of Scientific Advisory Board | no data | keine Daten | keine Daten | |
| Member of Scientific Advisory Board | less than a year | keine Daten | keine Daten | |
| Member of Scientific Advisory Board | 1.2yrs | keine Daten | keine Daten |
1.4yrs
Durchschnittliche Betriebszugehörigkeit
61yo
Durchschnittliches Alter
Erfahrener Vorstand: ACST's board of directors are not considered experienced ( 1.4 years average tenure), which suggests a new board.